ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kunitake, R
Right arrow Articles by Hara, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kunitake, R
Right arrow Articles by Hara, N
Eur Respir J 1998; 12: 920-925
Copyright © ERS Journals Ltd 1998


Clinical Trial

Expression of p53, p21 (Waf1/Cip1/Sdi1) and Fas antigen in collagen vascular and granulomatous lung diseases

R Kunitake, K Kuwano, H Miyazaki, M Kawasaki, N Hagimoto, M Fujita, Y Kaneko, and N Hara

Fas is expressed in various cells and transduces the cell death signal. p21 is a mediator of p53-dependent G1 arrest associated with deoxyribonucleic acid (DNA) damage. The upregulation of p53 and p21 associated with DNA damage in idiopathic pulmonary fibrosis has been described previously. In this study, p53, p21, and Fas expression and DNA damage were examined in interstitial pneumonia associated with collagen vascular diseases (CVD-IP). DNA damage was assessed by terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate biotin nick end-labelling (TUNEL) and p53, p21 and Fas proteins were detected by immunohistochemistry in 13 cases of CVD-IP, 13 of sarcoidosis, seven of hypersensitivity pneumonitis (HP) and eight control patients with normal lung parenchyma. TUNEL-positive signals were found in bronchiolar or alveolar epithelial cells in 11 of 13 (85%) specimens of CVD-IP, but not in sarcoidosis, HP or controls, except for a case of chronic HP with pulmonary fibrosis. p53, p21 and Fas were detected in bronchiolar or alveolar epithelial cells in nine (69%), 10 (77%) and 12 (92%) of 13 specimens of CVD-IP, respectively, but not in sarcoidosis, HP or controls, except for a case of chronic HP. These results suggest that the upregulation of p53, p21 and Fas in bronchiolar and alveolar epithelial cells associated with deoxyribonucleic acid damage may participate in the process of pulmonary fibrosis in interstitial pneumonia associated with collagen vascular diseases and chronic hypersensitivity pneumonitis.


This article has been cited by other articles:


Home page
Eur Respir JHome page
S. Hodge, G. Hodge, M. Holmes, and P. N. Reynolds
Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation
Eur. Respir. J., March 1, 2005; 25(3): 447 - 454.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Xaus, N. Besalduch, M. Comalada, J. Marcoval, R. Pujol, J. Mana, and A. Celada
High expression of p21Waf1 in sarcoid granulomas: a putative role for long-lasting inflammation
J. Leukoc. Biol., August 1, 2003; 74(2): 295 - 301.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. Matute-Bello, W. C. Liles, C. W. Frevert, M. Nakamura, K. Ballman, C. Vathanaprida, P. A. Kiener, and T. R. Martin
Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits
Am J Physiol Lung Cell Mol Physiol, August 1, 2001; 281(2): L328 - L335.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the European Respiratory Society.